Literature DB >> 11410213

Primary immunodeficiency diseases: an experimental model for molecular medicine.

A Fischer1.   

Abstract

Primary immunodeficiency diseases represent a vast array of inherited disorders of the immune system. Major advances in the understanding of genetic basis and molecular mechanisms have occurred within the past 10 years, as a result of the tools of modern genetics. About three quarters of 100 primary immunodeficiency diseases can now be reliably diagnosed with molecular probes. In many cases, gene identification has enabled significant insight into the physiopathology of the related conditions. Therapeutic progress based on protein engineering and possibly gene therapy will also ensue.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11410213     DOI: 10.1016/S0140-6736(00)04959-X

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  16 in total

Review 1.  Molecular aspects of primary immunodeficiencies: lessons from cytokine and other signaling pathways.

Authors:  Fabio Candotti; Luigi Notarangelo; Roberta Visconti; John O'Shea
Journal:  J Clin Invest       Date:  2002-05       Impact factor: 14.808

Review 2.  Update on clinical gene therapy in childhood.

Authors:  Waseem Qasim; H Bobby Gaspar; Adrian J Thrasher
Journal:  Arch Dis Child       Date:  2007-11       Impact factor: 3.791

3.  Immune globulin subcutaneous (human) vivaglobin: for the treatment of primary immunodeficiency diseases.

Authors: 
Journal:  P T       Date:  2009-06

4.  Genetic modification of somatic stem cells. The progress, problems and prospects of a new therapeutic technology.

Authors:  Fulvio Mavilio; Giuliana Ferrari
Journal:  EMBO Rep       Date:  2008-07       Impact factor: 8.807

5.  Idiopathic CD4+ T lymphocytopenia is associated with increases in immature/transitional B cells and serum levels of IL-7.

Authors:  Angela Malaspina; Susan Moir; Doreen G Chaitt; Catherine A Rehm; Shyam Kottilil; Judith Falloon; Anthony S Fauci
Journal:  Blood       Date:  2006-10-19       Impact factor: 22.113

6.  ZAP-70 restoration in mice by in vivo thymic electroporation.

Authors:  Magali Irla; Murielle Saade; Adrien Kissenpfennig; Lionel Franz Poulin; Lee Leserman; Patrice N Marche; Evelyne Jouvin-Marche; François Berger; Catherine Nguyen
Journal:  PLoS One       Date:  2008-04-30       Impact factor: 3.240

Review 7.  Allogeneic stem cell transplantation for treatment of immunodeficiency.

Authors:  Wilhelm Friedrich; Susanna M Müller
Journal:  Springer Semin Immunopathol       Date:  2004-09-11

8.  Zebrafish mutants with disrupted early T-cell and thymus development identified in early pressure screen.

Authors:  Nikolaus S Trede; Tatsuya Ota; Hirohide Kawasaki; Barry H Paw; Tammisty Katz; Bradley Demarest; Sarah Hutchinson; Yi Zhou; Candace Hersey; Agustin Zapata; Chris T Amemiya; Leonard I Zon
Journal:  Dev Dyn       Date:  2008-09       Impact factor: 3.780

Review 9.  Role of non-homologous end joining in V(D)J recombination.

Authors:  Shruti Malu; Vidyasagar Malshetty; Dailia Francis; Patricia Cortes
Journal:  Immunol Res       Date:  2012-12       Impact factor: 2.829

10.  Intravenous injection of a foamy virus vector to correct canine SCID-X1.

Authors:  Christopher R Burtner; Brian C Beard; Douglas R Kennedy; Martin E Wohlfahrt; Jennifer E Adair; Grant D Trobridge; Andrew M Scharenberg; Troy R Torgerson; David J Rawlings; Peter J Felsburg; Hans-Peter Kiem
Journal:  Blood       Date:  2014-03-18       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.